株式会社極東書店トップ ＞ 商品一覧 ＞ Duke's Handbook of Medicinal Plants of Latin America.
商品詳細
Duke's Handbook of Medicinal Plants of Latin America.
・ISBN 978-1-4200-4316-7 hard GB£ 260.00
￥82,368.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
| 著者・編者 | Duke, James A., |
|---|---|
| 出版社 | (CRC Press Inc, US) |
| 出版年月 | 2008 |
| ページ数 | 960 pp. |
| 言語 | ENG |
| ニュース番号 | ＜A03-13493＞ |
解説
Finalist for 2009 The Council on Botanical & Horticultural Libraries Literature Award!
A Comprehensive Guide Addressing Safety, Efficacy, and Suitability
About a quarter of all the medicines we use come from rainforest plants and more than 1,400 varieties of tropical plants are being investigated as potential cures for cancer. Curare comes from a tropical vine and quinine from the cinchona tree. A comprehensive guide to safety, efficacy, and suitability, Duke's Handbook of Medicinal Plants of Latin America responds to continuing interest in medicinal plants and the potential remedies they contain.
Determine Which Species Can Be Used for Specific Targets
The author of Green Pharmacy Herbal Handbook and CRC Handbook of Medicinal Herbs, James A. Duke covers roughly 500 of the more important Native Latin American medicinal plants in a highly organized format. After a brief introduction, each entry contains scientific and colloquial names, synonyms, reference to illustrations, notes, biological activities, medicinal indications, dosages, potential hazards, extracts, and references. This format supplies a starting point for determining which species can be used for specific targets.
Better Data Helps You Focus Your Search
Year-round moderate temperatures, abundant rainfall, and rich soils make tropical Latin America home to nearly 100,000 of the world's 300,000 known species of plants, and therefore home to untold numbers of potential cures. Focusing on 500 of the most well-known and well-studied plants, this book helps you focus your search for ammunition against constantly evolving pathogens and newly emerging diseases.